Mayo Clinic researchers study genetics, causes and new treatments for people with neurofibromatosis. Neurofibromatosis research is conducted by Mayo Clinic researchers in medical genetics, pediatric genetics and neurology.


See a list of publications by Mayo Clinic doctors on neurofibromatosis on PubMed, a service of the National Library of Medicine.

Dec. 24, 2015
  1. Ferri FF. Neurofibromatosis. In: Ferri's Clinical Advisor 2016. Philadelphia, Pa.: Mosby Elsevier; 2016. Accessed Nov. 11, 2015.
  2. Neurofibromatosis fact sheet. National Institute of Neurological Disorders and Stroke. Accessed Nov. 11, 2015.
  3. Korf BR. Neurofibromatosis type 1 (NF1): Pathogenesis, clinical features, and diagnosis. Accessed Nov. 10, 2015.
  4. Evans DG. Neurofibromatosis type 2. Accessed Nov. 10, 2015.
  5. Yohay K, et al. Schwannomatosis. Accessed Nov. 10, 2015.
  6. Korf BR. Neurofibromatosis type 1 (NF1): Management and prognosis. Accessed Nov. 10, 2015.
  7. Woodrow C, et al. Neurofibromatosis. Orthopaedics and Trauma. 2015;29:206.
  8. Goldblum JR, et al., eds. Benign tumors of peripheral nerves. In: Enzinger and Weiss's Soft Tissue Tumors. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 2014. Accessed Nov. 10, 2015.
  9. AskMayoExpert. Neurofibromatoses. Rochester, Minn.: Mayo Foundation for Medical Education and Research; 2015.
  10. Slattery WH. Neurofibromatosis type 2. Otolaryngologic Clinics of North America. 2015;48:443.
  11. Hirbe AC, et al. Neurofibromatosis type 1: A multidisciplinary approach to care. The Lancet Neurology. 2014;13:834.
  12. Flint PW, et al., eds. Stereotactic radiation treatment of benign tumors of the cranial base. In: Cummings Otolaryngology. 6th ed. Philadelphia, Pa.: Saunders Elsevier; 20154. Accessed Nov. 10, 2015.
  13. Riggin EA. Allscripts EPSi. Mayo Clinic, Rochester, Minn. Sept. 18, 2015.